Serum CEA, CA153, and CA125 are tumor markers that are frequently used in breast cancer screening and therapy efficacy monitoring (Cheung and Robertson, 2000; Seregni et al., 2004; Duffy, 2006; Duffy et al., 2010). Here, MUC1 is linked to breast carcinoma.